Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Wouldn’t your entire 401(K) be better diversified than betting all spend on a single rewards program? As loyalty prog...
A warning from SK Hynix could ripple through the NAND market and Sandisk stock. This guide breaks down what the hynix...
In late 2025, Berkshire added 8 million shares to a major energy producer, lifting its portfolio weight. This move po...
Brent crude has surged aggressively since January, up about 85% by spring. This article breaks down what drove the mo...
A sharp intraday drop in Micron shares sparked by AI memory demand concerns set off a broader discussion about pricin...
A sizzling 12.7% ultra-high-yield dividend can boost income, but safety matters. This guide shows how to screen, vali...
A surge of policy-driven inflation is shaking up markets as investors worry about how Washington decisions will tempe...
A Cytokinetics insider sale coincides with a stunning stock move. This article breaks down what the trade might signa...
When choosing where to park money or borrow, the smart move may be to use both banks. Dave Ramsey weighs Navy Federal...
A durable industrial stock with decades of dividend increases has quietly drifted from investor focus. This article e...
A respected investment firm hints that the crypto market might be near a bottom. Here’s what that could mean for Coin...